kat: a high-efficiency retroviral transduction system for primary human T lymphocytes - PubMed (original) (raw)
. 1994 Jan 1;83(1):43-50.
Affiliations
- PMID: 8274751
Free article
kat: a high-efficiency retroviral transduction system for primary human T lymphocytes
M H Finer et al. Blood. 1994.
Free article
Abstract
We describe a novel retroviral packaging system in which high titer amphotropic retrovirus was produced without the need to generate stable producer clones. kat expression vectors, which produce high levels of retroviral vector transcripts and retroviral packaging functions, were transfected into 293 cells followed by virus harvest 48 hours posttransfection. Viral titers as high as 3.8 proviral copies/cell/mL of frozen supernatant in 3T3 cells were obtained, 10- to 50-fold greater than transient viral titers reported using 3T3-based retroviral packaging lines. Cocultivation of primary human CD8+ T lymphocytes after transient transfection of 293 cells with kat plasmids resulted in transduction efficiencies of 10% to 40%, 5- to 10-fold greater compared to cocultivation with a high titer PA317 producer clone and significantly greater than previously reported results for transduction of primary human T lymphocytes with retroviral vectors. Virus produced using the kat system was shown to be free of detectable replication competent retrovirus by an extended provirus mobilization assay, demonstrating that this system is as safe as currently available stable packaging lines. The kat virus production system should be of general use for the rapid production of high titer viral supernatants, as well as for high-efficiency transduction hematopoietic cell types refractory to retroviral transduction.
Similar articles
- Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568 - Generation of retroviral vector for clinical studies using transient transfection.
Yang S, Delgado R, King SR, Woffendin C, Barker CS, Yang ZY, Xu L, Nolan GP, Nabel GJ. Yang S, et al. Hum Gene Ther. 1999 Jan 1;10(1):123-32. doi: 10.1089/10430349950019255. Hum Gene Ther. 1999. PMID: 10022537 - Improvement of retroviral packaging cell lines by introducing the polyomavirus early region.
Yoshimatsu T, Tamura M, Kuriyama S, Ikenaka K. Yoshimatsu T, et al. Hum Gene Ther. 1998 Jan 20;9(2):161-72. doi: 10.1089/hum.1998.9.2-161. Hum Gene Ther. 1998. PMID: 9472776 - Production of high-titer retroviral vectors and detection of replication-competent retroviruses.
Kim YS, Lim HK, Kim KJ. Kim YS, et al. Mol Cells. 1998 Feb 28;8(1):36-42. Mol Cells. 1998. PMID: 9571629 - Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y, Miller WM, Aiyar A. Chen Y, et al. Biotechnol Prog. 2005 Jan-Feb;21(1):274-82. doi: 10.1021/bp049865x. Biotechnol Prog. 2005. PMID: 15903266 Free PMC article.
Cited by
- CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV.
Kim GB, Hege K, Riley JL. Kim GB, et al. Front Immunol. 2019 Sep 27;10:2310. doi: 10.3389/fimmu.2019.02310. eCollection 2019. Front Immunol. 2019. PMID: 31611880 Free PMC article. Review. - A Lamina-Associated Domain Border Governs Nuclear Lamina Interactions, Transcription, and Recombination of the Tcrb Locus.
Chen S, Luperchio TR, Wong X, Doan EB, Byrd AT, Roy Choudhury K, Reddy KL, Krangel MS. Chen S, et al. Cell Rep. 2018 Nov 13;25(7):1729-1740.e6. doi: 10.1016/j.celrep.2018.10.052. Cell Rep. 2018. PMID: 30428344 Free PMC article. - RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.
Cortes JR, Ambesi-Impiombato A, Couronné L, Quinn SA, Kim CS, da Silva Almeida AC, West Z, Belver L, Martin MS, Scourzic L, Bhagat G, Bernard OA, Ferrando AA, Palomero T. Cortes JR, et al. Cancer Cell. 2018 Feb 12;33(2):259-273.e7. doi: 10.1016/j.ccell.2018.01.001. Epub 2018 Feb 2. Cancer Cell. 2018. PMID: 29398449 Free PMC article. - CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity.
Kueberuwa G, Kalaitsidou M, Cheadle E, Hawkins RE, Gilham DE. Kueberuwa G, et al. Mol Ther Oncolytics. 2017 Dec 19;8:41-51. doi: 10.1016/j.omto.2017.12.003. eCollection 2018 Mar 30. Mol Ther Oncolytics. 2017. PMID: 29367945 Free PMC article. - Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.
Hege KM, Bergsland EK, Fisher GA, Nemunaitis JJ, Warren RS, McArthur JG, Lin AA, Schlom J, June CH, Sherwin SA. Hege KM, et al. J Immunother Cancer. 2017 Mar 21;5:22. doi: 10.1186/s40425-017-0222-9. eCollection 2017. J Immunother Cancer. 2017. PMID: 28344808 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials